Results 71 to 80 of about 131,034 (316)
Research Priorities for Precision Medicine in NAFLD [PDF]
NAFLD is a multisystem condition and the leading cause of chronic liver disease globally. There are no approved NAFLD-specific dugs. To advance in the prevention and treatment of NAFLD, there is a clear need to better understand the pathophysiology and ...
Lazarus, Jeffrey, V +41 more
core +1 more source
Polystyrene nanoplastics exacerbate high‐fat diet‐induced metabolic dysfunction in an age‐dependent manner. Juvenile mice exhibit greater susceptibility, characterized by circadian disruption, impaired mitochondrial function, reduced energy metabolism, and enhanced hepatic lipid accumulation.
Peihao Xu +10 more
wiley +1 more source
Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children [PDF]
Non-alcoholic fatty liver disease (NAFLD) is a cluster of pathological liver conditions of emerging importance in overweight and obese children. NAFLD is associated with central obesity, insulin resistance, and dyslipidaemia, which are considered to be ...
Valerio Nobili, Anna Alisi
core
reservedUn eccesso calorico e uno stile di vita sedentario hanno portato a un’epidemia globale di obesità e sindrome metabolica. La conseguenza epatica della sindrome metabolica e dell’obesità è la steatosi non alcolica (NAFLD).
PERONI, FEDERICA
core
Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent metabolic chronic liver diseases in developed countries and puts the populations at risk of progression to liver necroinflammation, fibrosis, cirrhosis, and hepatocellular ...
Grattagliano I +15 more
core +1 more source
In normal hepatocytes, FBP1 forms compartmentalized complexes with PKM2, ENO1, and LDHA independent of its catalytic activity, inhibiting PKM2 activity and restricting excessive glycolysis. During MASLD progression, FBP1 downregulation markedly reduces the abundance of these complexes and releases the “hijacked” glycolytic enzymes, leading to PKM2 ...
Busong Wang +10 more
wiley +1 more source
Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver
Decheng Meng,1 Fengxia Zhang,2 Wenfei Yu,1 Xin Zhang,1 Guoliang Yin,1 Pengpeng Liang,3 Yanan Feng,1 Suwen Chen,1 Hongshuai Liu1 1The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250011, People’s Republic of ...
Meng D +8 more
doaj
INTRODUCTION: With the current consensus approach, the definition of non-alcoholic fatty liver disease has been changed to 'fatty liver disease associated with metabolic dysfunction' (MAFLD).
Çiğdem Mermutluoğlu, Mustafa Celen
doaj +1 more source
Serotonergic signaling as a pharmacological target for the treatment of NAFLD
reservedLa steatosi epatica non alcolica (NAFLD) è una delle patologie epatiche più diffuse al mondo ed è caratterizzata da un eccessivo accumulo di acidi grassi a livello degli epatociti.
MARCHIOTTO, ANNA
core

